publication venue for
- Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon-ion radiotherapy. 2023
- Concurrent immunotherapy and re-irradiation utilizing stereotactic body radiotherapy for recurrent high-grade gliomas. 2023
- Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial. 2022
- Leptomeningeal metastatic cells adopt two phenotypic states.. 5. 2020
- Epigenetic analysis identifies factors driving racial disparity in prostate cancer.. 2. 2018